Lamonzie Elodie, Vaillant Fanny, Abell Emma, Charron Sabine, El Hamrani Dounia, Quesson Bruno, Brette Fabien
Univ, Bordeaux, CRCTB, Inserm, Bordeaux, France.
IHU Liryc, Electrophysiology and Heart Modeling Institute, Bordeaux, France.
Front Physiol. 2022 Jul 7;13:952043. doi: 10.3389/fphys.2022.952043. eCollection 2022.
MRI is widely used in cardiology to characterize the structure and function of the heart. Currently, gadolinium-based contrast agents are widely used to improve sensitivity and specificity of diagnostic images. Recently, Manganese, a calcium analogue, has emerged as a complementary contrast agent with the potential to reveal remaining viable cells within altered tissue. Imaging applications may be limited by substantial toxicity of manganese. Indeed, cardiac safety of manganese is not yet comprehensively assessed. In this study we investigated the effect of MnCl (1-100 µM) on cardiac function. Hemodynamic function was determined using an isolated working rat heart preparation. HL-1 cardiac myocytes were used to investigate cell viability (calcein AM) and calcium cycling (Cal-520 a.m.). Rat ventricular cardiomyocytes were dissociated by enzymatic digestion. Action potentials and calcium currents were recorded using the patch clamp technique. MRI experiments were performed at 1.5T on formalin-fixed rat hearts, previously perfused with MnCl. MnCl perfusion from 1 up to 100 µM in isolated working hearts did not alter left ventricular hemodynamic parameters. Contractility and relaxation index were not altered up to 50 µM MnCl. In HL-1 cardiac myocytes, incubation with increasing concentrations of MnCl did not impact cell viability. The amplitude of the calcium transients were significantly reduced at 50 and 100 µM MnCl. In freshly isolated ventricular myocytes, action potential duration at 20, 50 and 90% of repolarization were not modified up to 10 µM of MnCl. L-type calcium current amplitude was significantly decreased by 50 and 100 µM of MnCl. MRI on heart perfused with 25 and 100 µM of MnCl showed a dose dependent decrease in the T1 relaxation time. In conclusion, our results show that low concentrations of MnCl (up to 25 µM) can be used as a contrast agent in MRI, without significant impact on cardiac hemodynamic or electrophysiology parameters.
磁共振成像(MRI)在心脏病学中被广泛用于表征心脏的结构和功能。目前,基于钆的造影剂被广泛用于提高诊断图像的敏感性和特异性。最近,锰,一种钙类似物,已成为一种补充造影剂,有潜力揭示病变组织内剩余的存活细胞。成像应用可能会受到锰的高毒性限制。事实上,锰对心脏的安全性尚未得到全面评估。在本研究中,我们研究了氯化锰(1 - 100 μM)对心脏功能的影响。使用离体工作大鼠心脏标本测定血流动力学功能。HL - 1心肌细胞用于研究细胞活力(钙黄绿素乙酰甲酯)和钙循环(Cal - 520上午)。大鼠心室心肌细胞通过酶消化解离。使用膜片钳技术记录动作电位和钙电流。在1.5T条件下对先前用氯化锰灌注的福尔马林固定大鼠心脏进行MRI实验。在离体工作心脏中,1至100 μM的氯化锰灌注并未改变左心室血流动力学参数。高达50 μM氯化锰时,收缩性和舒张指数未改变。在HL - 1心肌细胞中,用浓度递增的氯化锰孵育对细胞活力没有影响。在50和100 μM氯化锰时,钙瞬变的幅度显著降低。在新鲜分离的心室肌细胞中,高达10 μM氯化锰时,复极化20%、50%和90%时的动作电位持续时间未改变。50和100 μM氯化锰显著降低L型钙电流幅度。用25和100 μM氯化锰灌注心脏的MRI显示T1弛豫时间呈剂量依赖性降低。总之,我们的结果表明,低浓度的氯化锰(高达25 μM)可在MRI中用作造影剂,而对心脏血流动力学或电生理参数无显著影响。